These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1273915)

  • 21. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regeneration of transplanted allogeneic hemopoietic progenitor cells in mouse spleen organ cultures.
    von Melchner H; Bartlett PF
    Exp Hematol; 1981 Nov; 9(10):978-89. PubMed ID: 6118283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-associated alien alloantigens of BALB/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study.
    Parmiani G; Ballinari D; Sensi ML
    J Immunol; 1980 Feb; 124(2):662-8. PubMed ID: 6153203
    [No Abstract]   [Full Text] [Related]  

  • 24. Increase in testis luteinizing hormone receptor by estrogen in mice susceptible to Leydig cell tumors.
    Navickis RJ; Shimkin MB; Hsueh AJ
    Cancer Res; 1981 May; 41(5):1646-51. PubMed ID: 6260347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous Leydig cell tumors in inbred laboratory mice.
    Mähler M; Sundberg JP
    Lab Anim Sci; 1997 Apr; 47(2):148-52. PubMed ID: 9150493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth characteristics of tumors induced by transplantation into athymic mice of BALB/3T3 cells transformed in vitro by residue organics from drinking water.
    Kurzepa H; Kyriazis AP; Lang DR
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):131-8. PubMed ID: 6520719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice.
    Niederkorn J; Streilein JW; Shadduck JA
    Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):355-63. PubMed ID: 6782034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
    Schirrmacher V
    Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
    Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
    J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed hypersensitivity to simian virus 40 tumor cells in BALB-c mice demonstrated by a radioisotopic foot-pad assay.
    Paranjpe MS; Boone CW
    J Natl Cancer Inst; 1972 Feb; 48(2):563-6. PubMed ID: 4347042
    [No Abstract]   [Full Text] [Related]  

  • 31. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
    Basciani S; Brama M; Mariani S; De Luca G; Arizzi M; Vesci L; Pisano C; Dolci S; Spera G; Gnessi L
    Cancer Res; 2005 Mar; 65(5):1897-903. PubMed ID: 15753388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the timing of blood transfusion on experimental tumor growth.
    Francis DM; Clunie GJ
    J Surg Res; 1993 Mar; 54(3):237-41. PubMed ID: 8474239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
    Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
    Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered allotransplantability of BALB/c Leydig cell tumor after organ culture or cell suspension.
    Ninnemann JL; Good RA
    Transplantation; 1975 Jan; 19(1):42-7. PubMed ID: 804191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.
    Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G
    J Immunol; 1999 Jun; 162(11):6650-7. PubMed ID: 10352282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of treatment with neuraminidase on the immunogenicity of ATPC tumor cells].
    Iorio AM; Rivosecchi P; Santoni A; Fabiani L
    Boll Soc Ital Biol Sper; 1973 Mar; 49(9):462-6. PubMed ID: 4787510
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in the uptake of 2-deoxy-D-glucose in BALB-3T3 cells chemically transformed in culture.
    Oshiro Y; DiPaolo JA
    J Cell Physiol; 1974 Apr; 83(2):193-201. PubMed ID: 4822526
    [No Abstract]   [Full Text] [Related]  

  • 38. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
    Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
    J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of abl and raf with IL-7 signaling pathway and transformation of pre-B cells from resistant mice.
    Hilbert DM; Theisen PW; Rudikoff EK; Bauer SR
    Oncogene; 1998 Oct; 17(16):2125-35. PubMed ID: 9798684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lines of transformed mouse thymus cells. II. Cell morphology, karyology, ultrastructure and growth in vitro and in vivo].
    Shichkin VP; Iarilin AA; Gudima GO; Rodova MA
    Tsitologiia; 1987 Sep; 29(9):1036-40. PubMed ID: 3501622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.